NO20043547L - Aza-arylpiperaziner - Google Patents

Aza-arylpiperaziner

Info

Publication number: NO20043547L
Authority: NO; Norway
Prior art keywords: arylpiperazines; aza
Prior art date: 2002-01-29

Application number

NO20043547A

Other languages

English (en)

Inventor

Paul Hebeisen

David Reginald Adams

Jonathan Mark Bentley

Jonathan Richard Anthon Roffey

Hans G F Richter

Toby Jonathan Blench

Nathaniel Julius Thomas Monck

Stephan Roever

Sven Taylor

Original Assignee

Vernalis Res Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-01-29

Filing date

2004-08-25

Publication date

2004-08-25

2004-08-25 Application filed by Vernalis Res Ltd filed Critical Vernalis Res Ltd

2004-08-25 Publication of NO20043547L publication Critical patent/NO20043547L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Psychiatry (AREA)
Hematology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Reproductive Health (AREA)
Psychology (AREA)
Cardiology (AREA)
Dermatology (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Gynecology & Obstetrics (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Epoxy Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Hydrogenated Pyridines (AREA)

NO20043547A 2002-01-29 2004-08-25 Aza-arylpiperaziner NO20043547L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0202015.4A GB0202015D0 (en)	2002-01-29	2002-01-29	Piperazine Derivatives
PCT/EP2003/000459 WO2003064423A1 (en)	2002-01-29	2003-01-17	Aza-arylpiperazines

Publications (1)

Publication Number	Publication Date
NO20043547L true NO20043547L (no)	2004-08-25

Family

ID=9929954

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20043547A NO20043547L (no)	2002-01-29	2004-08-25	Aza-arylpiperaziner

Country Status (33)

Country	Link
US (1)	US7098337B2 (no)
EP (1)	EP1472255B1 (no)
JP (1)	JP4213042B2 (no)
KR (1)	KR100644004B1 (no)
CN (1)	CN1290847C (no)
AR (1)	AR038237A1 (no)
AT (1)	ATE318817T1 (no)
AU (1)	AU2003205622B2 (no)
BR (1)	BR0307291A (no)
CA (1)	CA2472954C (no)
DE (1)	DE60303791T2 (no)
DK (1)	DK1472255T3 (no)
EA (1)	EA200400881A1 (no)
EC (1)	ECSP045208A (no)
ES (1)	ES2259757T3 (no)
GB (1)	GB0202015D0 (no)
GT (1)	GT200300015A (no)
HR (1)	HRP20040653A2 (no)
IL (1)	IL162727A0 (no)
MA (1)	MA27097A1 (no)
MX (1)	MXPA04007147A (no)
NO (1)	NO20043547L (no)
PA (1)	PA8564001A1 (no)
PE (1)	PE20030847A1 (no)
PL (1)	PL371922A1 (no)
PT (1)	PT1472255E (no)
RS (1)	RS65704A (no)
SI (1)	SI1472255T1 (no)
TN (1)	TNSN04136A1 (no)
TW (1)	TW200307683A (no)
UY (1)	UY27627A1 (no)
WO (1)	WO2003064423A1 (no)
ZA (1)	ZA200405458B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7405210B2 (en)	2003-05-21	2008-07-29	Osi Pharmaceuticals, Inc.	Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
ATE473974T1 (de) *	2003-05-21	2010-07-15	Prosidion Ltd	Pyrrolopyridin-2-carbonsäuren als hemmer der glycogenphosphorylase
GB0314967D0 (en) *	2003-06-26	2003-07-30	Hoffmann La Roche	Piperazine derivatives
CA2543197A1 (en) *	2003-10-24	2005-05-06	Solvay Pharmaceuticals Gmbh	Combination treatment of obesity involving selective cb1-antagonists and lipase inhibitors
AR046132A1 (es) *	2003-10-24	2005-11-23	Solvay Pharm Gmbh	Composicin farmaceutica que contiene al menos un compuesto con actividad de receptor de cb1, o un profarmaco , tautomero o sal del mismo, como componente activo adecuado para el tratamiento y/o profilaxis de enfermedades relacionadas con el receptor cb1 en pacientes juveniles y/o para el tratamiento
EP2248524A3 (en)	2004-08-25	2011-03-09	Takeda Pharmaceutical Company Limited	Preventives/remedies for stress urinary incontinence and method of screening the same
JP2008517976A (ja)	2004-10-25	2008-05-29	ゾルファイファーマスーティカルズゲゼルシャフトミットベシュレンクテルハフツング	Ｃｂ１カンナビノイド受容体拮抗薬及びカリウムチャンネルオープナーから成る、真性糖尿病１型、肥満及び関連症状の治療用の医薬組成物
CA2609634C (en) *	2005-05-03	2011-02-01	F. Hoffmann-La Roche Ag	Tetracyclic azapyrazinoindolines as 5-ht2 ligands
WO2006125179A1 (en) *	2005-05-19	2006-11-23	Xenon Pharmaceuticals Inc.	Tricyclic compounds and their uses as therapeutic agents
ATE485294T1 (de) *	2005-11-18	2010-11-15	Hoffmann La Roche	Azaindol-2-carboxamid-derivate
CA2631128A1 (en) *	2005-12-09	2007-06-14	F. Hoffmann-La Roche Ag	Tricyclic amide derivatives useful for treating obesity
WO2007068641A1 (en)	2005-12-16	2007-06-21	F. Hoffmann-La Roche Ag	Pyrrolo [2 , 3-b] pyridine derivatives as h3 receptor modulators
US8158617B2 (en)	2006-05-16	2012-04-17	Takeda Pharmaceutical Company Limited	Fused heterocyclic compound and use thereof
KR20090047458A (ko)	2006-08-08	2009-05-12	사노피-아벤티스	아릴아미노아릴-알킬-치환된 이미다졸리딘-2,4-디온, 이의 제조방법, 이들 화합물을 포함하는 약제 및 이의 용도
EP2216023A4 (en)	2007-11-15	2013-03-13	Takeda Pharmaceutical	CONDENSED PYRIDINE DERIVATIVE AND ITS USE
UY31968A (es)	2008-07-09	2010-01-29	Sanofi Aventis	Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
WO2010068601A1 (en)	2008-12-08	2010-06-17	Sanofi-Aventis	A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
WO2011023754A1 (en)	2009-08-26	2011-03-03	Sanofi-Aventis	Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
JPWO2011071136A1 (ja)	2009-12-11	2013-04-22	アステラス製薬株式会社	線維筋痛症治療剤
FR2960876B1 (fr) *	2010-06-03	2012-07-27	Sanofi Aventis	Derives de 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide leur preparation et leur application en therapeutique.
US8710050B2 (en)	2011-03-08	2014-04-29	Sanofi	Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120056A1 (de)	2011-03-08	2012-09-13	Sanofi	Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120058A1 (de)	2011-03-08	2012-09-13	Sanofi	Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120051A1 (de)	2011-03-08	2012-09-13	Sanofi	Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8809324B2 (en)	2011-03-08	2014-08-19	Sanofi	Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
WO2012120052A1 (de)	2011-03-08	2012-09-13	Sanofi	Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2012120053A1 (de)	2011-03-08	2012-09-13	Sanofi	Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683703B1 (de)	2011-03-08	2015-05-27	Sanofi	Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8828994B2 (en)	2011-03-08	2014-09-09	Sanofi	Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2841417A1 (en) *	2012-04-26	2015-03-04	Francis Xavier Tavares	Synthesis of lactams
EP2880036B1 (en) *	2012-08-06	2017-03-08	F. Hoffmann-La Roche AG	Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-1-one
WO2015066344A1 (en)	2013-11-01	2015-05-07	Arena Pharmaceuticals, Inc.	5-ht2c receptor agonists and compositions and methods of use
AU2017313908C1 (en) *	2016-08-19	2022-06-09	Arena Pharmaceuticals, Inc.	5-HT2C receptor agonists and compositions and methods of use
WO2019131902A1 (ja)	2017-12-27	2019-07-04	武田薬品工業株式会社	腹圧性尿失禁および便失禁の治療薬

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1247547A (en) *	1983-06-22	1988-12-28	Paul Hadvary	Leucine derivatives
CA1270837A (en) *	1984-12-21	1990-06-26	Hoffmann-La Roche Limited	Oxetanones
CA1328881C (en)	1984-12-21	1994-04-26	Pierre Barbier	Process for the manufacture of oxetanones
CA2035972C (en) *	1990-02-23	2006-07-11	Martin Karpf	Process for the preparation of oxetanones
US5274143A (en)	1991-07-23	1993-12-28	Hoffmann-La Roche Inc.	Process for the preparation of (R)-3-hexyl-5,6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one and (R)-5,6-dihydro-6-undecyl-2H-pyran-2,4(3H)-dione
US6004996A (en) *	1997-02-05	1999-12-21	Hoffman-La Roche Inc.	Tetrahydrolipstatin containing compositions
US6267952B1 (en)	1998-01-09	2001-07-31	Geltex Pharmaceuticals, Inc.	Lipase inhibiting polymers
KR20010079635A (ko)	1998-08-14	2001-08-22	프리돌린 클라우스너, 롤란드 비. 보레르	리파아제 저해제를 함유하는 약학 조성물
KR20010079636A (ko)	1998-08-14	2001-08-22	프리돌린 클라우스너, 롤란드 비. 보레르	라이페이즈 저해제 및 키토산을 포함하는 약학 조성물
GB9902047D0 (en) *	1999-01-29	1999-03-17	Cerebrus Ltd	Chemical compounds XI
FR2799757B1 (fr) *	1999-10-15	2001-12-14	Adir	Nouveaux derives polycycliques azaindoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

2002
- 2002-01-29 GB GBGB0202015.4A patent/GB0202015D0/en not_active Ceased
2003
- 2003-01-17 KR KR1020047011619A patent/KR100644004B1/ko not_active Expired - Fee Related
- 2003-01-17 EA EA200400881A patent/EA200400881A1/ru unknown
- 2003-01-17 JP JP2003564046A patent/JP4213042B2/ja not_active Expired - Fee Related
- 2003-01-17 CN CNB03802943XA patent/CN1290847C/zh not_active Expired - Fee Related
- 2003-01-17 BR BR0307291-6A patent/BR0307291A/pt not_active IP Right Cessation
- 2003-01-17 IL IL16272703A patent/IL162727A0/xx unknown
- 2003-01-17 HR HR20040653A patent/HRP20040653A2/hr not_active Application Discontinuation
- 2003-01-17 ES ES03702462T patent/ES2259757T3/es not_active Expired - Lifetime
- 2003-01-17 CA CA002472954A patent/CA2472954C/en not_active Expired - Fee Related
- 2003-01-17 MX MXPA04007147A patent/MXPA04007147A/es unknown
- 2003-01-17 PT PT03702462T patent/PT1472255E/pt unknown
- 2003-01-17 SI SI200330231T patent/SI1472255T1/sl unknown
- 2003-01-17 DK DK03702462T patent/DK1472255T3/da active
- 2003-01-17 WO PCT/EP2003/000459 patent/WO2003064423A1/en not_active Ceased
- 2003-01-17 RS YU65704A patent/RS65704A/sr unknown
- 2003-01-17 EP EP03702462A patent/EP1472255B1/en not_active Expired - Lifetime
- 2003-01-17 AU AU2003205622A patent/AU2003205622B2/en not_active Ceased
- 2003-01-17 DE DE60303791T patent/DE60303791T2/de not_active Expired - Lifetime
- 2003-01-17 AT AT03702462T patent/ATE318817T1/de active
- 2003-01-17 PL PL03371922A patent/PL371922A1/xx not_active Application Discontinuation
- 2003-01-24 US US10/350,616 patent/US7098337B2/en not_active Expired - Fee Related
- 2003-01-24 PE PE2003000073A patent/PE20030847A1/es not_active Application Discontinuation
- 2003-01-27 AR ARP030100229A patent/AR038237A1/es unknown
- 2003-01-27 GT GT200300015A patent/GT200300015A/es unknown
- 2003-01-28 TW TW092101825A patent/TW200307683A/zh unknown
- 2003-01-28 PA PA20038564001A patent/PA8564001A1/es unknown
- 2003-01-28 UY UY27627A patent/UY27627A1/es not_active Application Discontinuation
2004
- 2004-06-30 MA MA27756A patent/MA27097A1/fr unknown
- 2004-07-08 ZA ZA200405458A patent/ZA200405458B/en unknown
- 2004-07-22 TN TNP2004000136A patent/TNSN04136A1/en unknown
- 2004-07-27 EC EC2004005208A patent/ECSP045208A/es unknown
- 2004-08-25 NO NO20043547A patent/NO20043547L/no unknown

Also Published As

Publication number	Publication date
CA2472954A1 (en)	2003-08-07
PA8564001A1 (es)	2003-09-05
TW200307683A (en)	2003-12-16
MA27097A1 (fr)	2004-12-20
KR100644004B1 (ko)	2006-11-10
TNSN04136A1 (en)	2007-03-12
IL162727A0 (en)	2005-11-20
JP2005521671A (ja)	2005-07-21
EA200400881A1 (ru)	2005-02-24
DK1472255T3 (da)	2006-07-10
ZA200405458B (en)	2006-02-22
CA2472954C (en)	2009-04-28
ATE318817T1 (de)	2006-03-15
EP1472255A1 (en)	2004-11-03
KR20040077885A (ko)	2004-09-07
DE60303791D1 (en)	2006-04-27
US20030207888A1 (en)	2003-11-06
CN1290847C (zh)	2006-12-20
EP1472255B1 (en)	2006-03-01
GB0202015D0 (en)	2002-03-13
MXPA04007147A (es)	2004-10-29
HRP20040653A2 (hr)	2005-06-30
GT200300015A (es)	2003-09-12
ES2259757T3 (es)	2006-10-16
BR0307291A (pt)	2004-12-07
US7098337B2 (en)	2006-08-29
ECSP045208A (es)	2004-09-28
DE60303791T2 (de)	2006-11-02
UY27627A1 (es)	2003-07-31
AR038237A1 (es)	2005-01-05
AU2003205622B2 (en)	2006-10-19
RS65704A (sr)	2006-10-27
JP4213042B2 (ja)	2009-01-21
WO2003064423A1 (en)	2003-08-07
PE20030847A1 (es)	2003-10-21
PT1472255E (pt)	2006-06-30
PL371922A1 (en)	2005-07-11
SI1472255T1 (sl)	2006-06-30
CN1625558A (zh)	2005-06-08

Publication	Publication Date	Title
ATE457980T1 (de)	2010-03-15	Aryloxime
NO20044776L (no)	2004-12-07	Quinolinonderivater
DE50305852D1 (de)	2007-01-11	Einspritzventil
DE50306589D1 (de)	2007-04-05	Wischblatt
DE50310083D1 (de)	2008-08-14	Phthalocyaninpigmentzubereitungen
ATE318817T1 (de)	2006-03-15	Aza-arylpiperazine
ATE427876T1 (de)	2009-04-15	Luftkissenboot
DE50212360D1 (de)	2008-07-24	Anfahrhilfesteuerungsvorrichtung
DE50301200D1 (de)	2005-10-20	Wischblatt
DE50305301D1 (de)	2006-11-16	Einspritzventil
ATE349458T1 (de)	2007-01-15	Etonogestrelester
DE60328453D1 (de)	2009-09-03	Fahrzeugaufhängevorrichtung
DE50309536D1 (de)	2008-05-15	Fadenabsaugvorrichtung
DE50310481D1 (de)	2008-10-23	Röntgenstativ
ATA1572002A (de)	2003-06-15	Managementspleisskassette
DE50307971D1 (de)	2007-09-27	Gelenklager
DE50301960D1 (de)	2006-01-26	Hydrolager
DE50302660D1 (de)	2006-05-11	Stopfmachine
DE50301464D1 (de)	2005-12-01	Schraubensicherung
DE50309499D1 (de)	2008-05-08	Librierwerkzeugen
ATA4142004A (de)	2005-12-15	Trägerverbau
ATE469773T1 (de)	2010-06-15	Zugöse
DE50305973D1 (de)	2007-01-25	Auffangwanne
DE50307628D1 (de)	2007-08-16	Getraenkehalter
DE50303317D1 (de)	2006-06-14	Einschub-leistungsschalter